Bruker Corporation Company Profile (NASDAQ:BRKR)

About Bruker Corporation (NASDAQ:BRKR)

Bruker Corporation logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:BRKR
  • CUSIP: 11679410
  • Web:
  • Market Cap: $4.66217 billion
  • Outstanding Shares: 159,768,000
Average Prices:
  • 50 Day Moving Avg: $28.56
  • 200 Day Moving Avg: $25.18
  • 52 Week Range: $19.58 - $30.02
  • Trailing P/E Ratio: 30.64
  • Foreward P/E Ratio: 23.27
  • P/E Growth: 3.93
Sales & Book Value:
  • Annual Revenue: $1.62 billion
  • Price / Sales: 2.85
  • Book Value: $4.54 per share
  • Price / Book: 6.36
  • Annual Dividend: $0.16
  • Dividend Yield: 0.6%
  • EBIDTA: $264.3 million
  • Net Margins: 9.35%
  • Return on Equity: 26.88%
  • Return on Assets: 10.49%
  • Debt-to-Equity Ratio: 0.53%
  • Current Ratio: 2.45%
  • Quick Ratio: 1.53%
  • Average Volume: 746,940 shs.
  • Beta: 1.1
  • Short Ratio: 3.39
Frequently Asked Questions for Bruker Corporation (NASDAQ:BRKR)

What is Bruker Corporation's stock symbol?

Bruker Corporation trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker Corporation pay dividends? What is the dividend yield for Bruker Corporation?

Bruker Corporation declared a quarterly dividend on Monday, May 15th. Shareholders of record on Monday, June 5th will be paid a dividend of $0.04 per share on Friday, June 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date is Thursday, June 1st. View Bruker Corporation's Dividend History.

How will Bruker Corporation's stock buyback program work?

Bruker Corporation declared that its board has approved a stock buyback program on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.

How were Bruker Corporation's earnings last quarter?

Bruker Corporation (NASDAQ:BRKR) announced its quarterly earnings results on Wednesday, May, 3rd. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.00. The firm earned $384.90 million during the quarter, compared to the consensus estimate of $372.59 million. Bruker Corporation had a net margin of 9.35% and a return on equity of 26.88%. The business's quarterly revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.21 EPS. View Bruker Corporation's Earnings History.

When will Bruker Corporation make its next earnings announcement?

Bruker Corporation is scheduled to release their next quarterly earnings announcement on Thursday, August, 3rd 2017. View Earnings Estimates for Bruker Corporation.

What guidance has Bruker Corporation issued on next quarter's earnings?

Bruker Corporation issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided EPS guidance of $1.05-1.09 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.08. The company issued revenue guidance of $1.64-1.67 billion, compared to the consensus revenue estimate of $1.65 billion.

Where is Bruker Corporation's stock going? Where will Bruker Corporation's stock price be in 2017?

14 equities research analysts have issued 1 year price objectives for Bruker Corporation's stock. Their predictions range from $20.00 to $30.00. On average, they anticipate Bruker Corporation's stock price to reach $25.82 in the next year. View Analyst Ratings for Bruker Corporation.

What are analysts saying about Bruker Corporation stock?

Here are some recent quotes from research analysts about Bruker Corporation stock:

  • 1. According to Zacks Investment Research, "Bruker’s latest spree of product development is encouraging, the latest launch being the AVANCE NEO platform, a next-generation NMR console. The company’s strategic acquisition activity also encourages us. Also the cost-reduction action previously adopted by the company in its Nano-surfaces business played its role suitably. The company's solid cash balance on the back of improved free cash flow is indicative of strong fundamentals. Above all, the company’s raised revenue guidance also holds optimism indicating promising performance ahead. On the flip side, over the last one year, Bruker is trading below the Zacks categorized Instruments-Scientific industry. We are also discouraged with the company's year-over-year decline in organic revenues in the last reported first quarter. We are also concerned about currency fluctuations, competitive landscape and macroeconomic headwinds which are the major woes for Bruker." (7/6/2017)
  • 2. Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • 3. Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)
  • 4. Cantor Fitzgerald analysts commented, "CytoSorbents announced that the company has now received a permanent, dedicated, reimbursement procedure code for CytoSorb in Germany." This is positive news." (12/7/2016)

Who are some of Bruker Corporation's key competitors?

Who are Bruker Corporation's key executives?

Bruker Corporation's management team includes the folowing people:

  • Frank H. Laukien Ph.D., Chairman of the Board, President, Chief Executive Officer
  • Anthony L. Mattacchione, Chief Financial Officer, Senior Vice President
  • Juergen Srega, President of Bruker CALID Group and Bruker Daltonics Division
  • Mark Robert Munch Ph.D., Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division
  • William A. Linton, Lead Independent Director
  • Joerg C. Laukien, Director
  • Cynthia M. Friend Ph.D., Independent Director
  • Marc A. Kastner Ph.D., Independent Director
  • Richard D. Kniss, Independent Director

Who owns Bruker Corporation stock?

Bruker Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include First Quadrant L P CA (0.52%), BTIM Corp. (0.51%), Thompson Rubinstein Investment Management Inc. OR (0.10%), GW&K Investment Management LLC (0.05%), Legato Capital Management LLC (0.02%) and NN Investment Partners Holdings N.V. (0.02%). Company insiders that own Bruker Corporation stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer, Richard Kniss and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker Corporation.

Who sold Bruker Corporation stock? Who is selling Bruker Corporation stock?

Bruker Corporation's stock was sold by a variety of institutional investors in the last quarter, including BTIM Corp., GW&K Investment Management LLC and US Bancorp DE. Company insiders that have sold Bruker Corporation stock in the last year include Ingen Chris Van, Mark Munch and Richard Kniss. View Insider Buying and Selling for Bruker Corporation.

Who bought Bruker Corporation stock? Who is buying Bruker Corporation stock?

Bruker Corporation's stock was purchased by a variety of institutional investors in the last quarter, including First Quadrant L P CA, Legato Capital Management LLC, NN Investment Partners Holdings N.V. and Aperio Group LLC. Company insiders that have bought Bruker Corporation stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker Corporation.

How do I buy Bruker Corporation stock?

Shares of Bruker Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker Corporation's stock price today?

One share of Bruker Corporation stock can currently be purchased for approximately $28.86.

MarketBeat Community Rating for Bruker Corporation (NASDAQ BRKR)
Community Ranking:  2.2 out of 5 ( )
Outperform Votes:  241 (Vote Outperform)
Underperform Votes:  301 (Vote Underperform)
Total Votes:  542
MarketBeat's community ratings are surveys of what our community members think about Bruker Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bruker Corporation (NASDAQ:BRKR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 10 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $25.82 (10.54% downside)

Analysts' Ratings History for Bruker Corporation (NASDAQ:BRKR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017Barclays PLCReiterated RatingEqual Weight$26.00 -> $30.00LowView Rating Details
7/14/2017Cowen and CompanyReiterated RatingHold$29.00LowView Rating Details
7/12/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformMediumView Rating Details
5/15/2017Jefferies Group LLCReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche Bank AGBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/15/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00N/AView Rating Details
12/14/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$23.00 -> $20.00N/AView Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00N/AView Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
4/5/2016Bank of America CorporationDowngradeNeutral -> UnderperformN/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$21.00N/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00N/AView Rating Details
10/15/2015Citigroup Inc.Lower Price TargetNeutral$22.00 -> $20.00N/AView Rating Details
8/27/2015Maxim GroupInitiated CoverageHold$22.00N/AView Rating Details
(Data available from 7/25/2015 forward)


Earnings History for Bruker Corporation (NASDAQ:BRKR)
Earnings by Quarter for Bruker Corporation (NASDAQ:BRKR)
Earnings History by Quarter for Bruker Corporation (NASDAQ BRKR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2017$0.20N/AView Earnings Details
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bruker Corporation (NASDAQ:BRKR)
2017 EPS Consensus Estimate: $1.08
2018 EPS Consensus Estimate: $1.27
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.18$0.21$0.19
Q2 20173$0.17$0.21$0.19
Q3 20173$0.26$0.27$0.27
Q4 20173$0.42$0.45$0.43
Q1 20182$0.22$0.29$0.26
Q2 20182$0.26$0.28$0.27
Q3 20182$0.31$0.32$0.32
Q4 20182$0.40$0.45$0.43
(Data provided by Zacks Investment Research)


Current Dividend Information for Bruker Corporation (NASDAQ:BRKR)
Most Recent Dividend:6/23/2017
Annual Dividend:$0.16
Dividend Yield:0.55%
Payout Ratio:17.02% (Trailing 12 Months of Earnings)
14.55% (Based on This Year's Estimates)
12.90% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker Corporation (NASDAQ:BRKR)

Dividend History by Quarter for Bruker Corporation (NASDAQ BRKR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bruker Corporation (NASDAQ:BRKR)
Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 67.44%
Insider Trades by Quarter for Bruker Corporation (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)
Insider Trades by Quarter for Bruker Corporation (NASDAQ:BRKR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.00View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.00View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.00View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.00View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.60View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.00View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.00View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Bruker Corporation (NASDAQ:BRKR)
Latest Headlines for Bruker Corporation (NASDAQ:BRKR)
DateHeadline logoBruker Corporation (BRKR) Scheduled to Post Earnings on Monday - July 24 at 8:06 AM logoBruker Announces Date and Time of Second Quarter 2017 Earnings Release and Webcast - July 20 at 6:23 PM logoBruker Corporation (BRKR) Receives "Equal Weight" Rating from Barclays PLC - July 17 at 10:20 PM logoHere's Why Investors Should Invest in Bruker (BRKR) Now - July 17 at 5:06 PM logoBruker Corporation (BRKR) Earns Hold Rating from Cowen and Company - July 15 at 8:06 AM logoIBM to Report Q2 Earnings: Disappointment in Store? - July 14 at 11:41 PM logoBruker Corporation (BRKR) Downgraded by Wells Fargo & Company to "Underperform" - July 12 at 9:34 PM logoBruker Corporation (NASDAQ:BRKR) Upgraded by Zacks Investment Research to Buy - July 6 at 12:48 PM logoBruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of "Hold" from Analysts - July 3 at 10:24 PM logoBruker Corporation (BRKR) Expected to Announce Quarterly Sales of $381.18 Million - July 1 at 8:16 AM logoBruker Corporation (BRKR) Expected to Announce Earnings of $0.20 Per Share - June 29 at 8:32 PM logoBruker Announces Novel NMR Phenomics Research Capabilities - June 26 at 4:40 PM logoBillionaire Surfaces on Stock Surge of Scientific Device Maker - June 26 at 4:40 PM logoAnalysts Set Expectations for Bruker Corporation's FY2018 Earnings (BRKR) - June 26 at 10:42 AM logoInsider Selling: Bruker Corporation (BRKR) Director Sells 19,900 Shares of Stock - June 15 at 1:20 PM logoBruker Corporation (BRKR) Director Sells $677,520.00 in Stock - June 14 at 4:30 PM logoBruker Co. (BRKR) Receives Average Rating of "Hold" from Brokerages - June 9 at 5:54 PM logoInsider Selling: Bruker Co. (BRKR) VP Sells 73,724 Shares of Stock - June 9 at 10:34 AM logoBruker Grows on NMR & Nano Businesses amid Several Odds - June 8 at 4:56 PM logo$381.18 Million in Sales Expected for Bruker Co. (BRKR) This Quarter - June 7 at 9:05 AM logoBruker Co. (BRKR) Expected to Announce Earnings of $0.21 Per Share - June 5 at 6:26 PM logoBruker Introduces Novel Mass Spectrometry Solutions for MALDI Imaging, Metabolomics, Proteoform Profiling and Toxicology at ASMS 2017 - June 5 at 12:36 PM logoBruker (BRKR) Up 7.7% Since Earnings Report: Can It Continue? - June 5 at 12:36 PM logoBruker (BRKR) Board of Directors Approves Share Repurchase Program - June 4 at 11:08 AM logoBruker Corp. : BRKR-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 2, 2017 - June 2 at 5:25 PM logoBruker Introduces New Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control at the ASM Microbe 2017 Meeting - June 1 at 4:30 PM logoBruker Corp. :BRKR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 23, 2017 - May 23 at 1:00 PM logoBruker Co. (BRKR) CEO Frank H. Laukien Purchases 3,200 Shares - May 22 at 1:28 PM logoBruker Launches the S8 TIGER™ Series 2 WDXRF System for Elemental Analysis in Industrial and Academic Research and Materials Quality Control - May 22 at 12:28 PM logoBruker Co. (BRKR) CEO Purchases $1,914,060.00 in Stock - May 19 at 4:24 PM logoInsider Buying: Bruker Co. (BRKR) CEO Purchases 1,920 Shares of Stock - May 17 at 1:22 PM logoBruker Co. Announces Quarterly Dividend of $0.04 (BRKR) - May 15 at 5:48 PM logoBruker Co. (BRKR) Receives Consensus Rating of "Hold" from Brokerages - May 12 at 10:41 PM logoBruker Announces New $225 Million Share Repurchase Program and Quarterly Dividend - May 12 at 3:27 PM logoBruker Co. (BRKR) to Post FY2017 Earnings of $1.10 Per Share, Cantor Fitzgerald Forecasts - May 11 at 11:28 AM logoBruker Co. (BRKR) Short Interest Up 4.8% in April - May 11 at 7:12 AM logo Analysts Anticipate Bruker Co. (BRKR) Will Announce Earnings of $0.21 Per Share - May 10 at 8:04 AM logoBruker Acquires Emerging Light Sheet Microscopy Company Luxendo - May 8 at 10:19 AM logoQ3 2017 EPS Estimates for Bruker Co. Lifted by Leerink Swann (BRKR) - May 8 at 9:06 AM logoJefferies Group LLC Reaffirms Buy Rating for Bruker Co. (BRKR) - May 7 at 10:32 AM logoDeutsche Bank AG Reaffirms Hold Rating for Bruker Co. (BRKR) - May 5 at 3:06 PM logoQ2 2017 EPS Estimates for Bruker Co. Lowered by Jefferies Group (BRKR) - May 5 at 9:54 AM logoLeerink Swann Weighs in on Bruker Co.'s Q2 2017 Earnings (BRKR) - May 5 at 9:54 AM logoBruker Co. (BRKR) Stock Rating Reaffirmed by Cowen and Company - May 4 at 11:27 AM logoInvestor Network: Bruker Corporation to Host Earnings Call - May 4 at 10:14 AM logoBruker Reports First Quarter 2017 Financial Results - May 4 at 10:14 AM logoEdited Transcript of BRKR earnings conference call or presentation 3-May-17 8:45pm GMT - May 4 at 10:14 AM logoBruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates - May 4 at 10:14 AM logoBruker Co. (BRKR) Issues Quarterly Earnings Results, Hits Expectations - May 4 at 1:25 AM logoBruker Co. (BRKR) Releases FY17 Earnings Guidance - May 4 at 1:13 AM



Bruker Corporation (BRKR) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff